loading

Finanzdaten der Axsome Therapeutics Inc-Aktie (AXSM)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
4.85%
75.00
71.53 57.79 46.70 94.58
Operating Expenses
16.21%
142.27
169.80 119.91 111.76 100.95
Benefits Costs and Expenses
15.92%
143.36
170.51 120.67 114.49 103.21
Costs And Expenses
16.21%
142.27
169.80 119.91 111.76 100.95
Operating Income/Loss
31.54%
-67.28
-98.27 -62.12 -65.06 -6.374
Income/Loss From Continuing Operations Before Tax
30.94%
-68.36
-98.98 -62.88 -67.79 -8.638
Income Tax Expense/Benefit
100.00%
-
-0.325 -0.678 -0.617 2.58
Income/Loss From Continuing Operations After Tax
30.71%
-68.36
-98.65 -62.20 -67.17 -11.22
Net Income/Loss
30.71%
-68.36
-98.65 -62.20 -67.17 -11.22
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
7,284%
47.39
0.6418 47.12 43.67 43.52
Diluted Average Shares
7,284%
47.39
0.6418 47.12 43.67 43.52
Basic Earnings Per Share
32.39%
-1.44
-2.13 -1.32 -1.54 -0.26
Diluted Earnings Per Share
32.39%
-1.44
-2.13 -1.32 -1.54 -0.26
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Kapitalisierung:     |  Volumen (24h):